Skip to search formSkip to main contentSkip to account menu
You are currently offline. Some features of the site may not work correctly.

Sulfonylurea Compounds

Known as: Compounds, Sulfonylurea, sulphonylurea, sulphonylureas 
National Institutes of Health

Related topics

Related topics

48 relations

Narrower (31)

4-dextran-sulfonylurea-piretanideBM 27BM 531BM 567
Expand

Broader (3)

AntidiabeticsHypoglycemic AgentsSulfonamides
GlyburideIn BloodSulfonylurea [EPC]Sulfonylurea:MCnc:Pt:Urine:Qn
Expand

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2011
Review
2011
Interventions for latent autoimmune diabetes (LADA) in adults.
BACKGROUND Latent autoimmune diabetes in adults (LADA) is a slowly developing type 1 diabetes. OBJECTIVES To compare… 
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 5
Highly Cited
2009
Highly Cited
2009
From the Triumvirate to the Ominous Octet: A New Paradigm for the Treatment of Type 2 Diabetes Mellitus
Insulin resistance in muscle and liver and β-cell failure represent the core pathophysiologic defects in type 2 diabetes. It now… 
  • figure 1
  • figure 3
  • figure 2
  • figure 4
  • figure 5
Highly Cited
2008
Highly Cited
2008
10-year follow-up of intensive glucose control in type 2 diabetes.
BACKGROUND During the United Kingdom Prospective Diabetes Study (UKPDS), patients with type 2 diabetes mellitus who received… 
  • figure 1
  • figure 2
  • table 2
Review
2008
Review
2008
Obesity
Editor's Note: This issue of In the Clinic has been updated. More than 30% of U.S. adults are obese (1). Generally defined as a… 
Highly Cited
1999
Highly Cited
1999
Glycemic control with diet, sulfonylurea, metformin, or insulin in patients with type 2 diabetes mellitus: progressive requirement for multiple therapies (UKPDS 49). UK Prospective Diabetes Study…
CONTEXT Treatment with diet alone, insulin, sulfonylurea, or metformin is known to improve glycemia in patients with type 2… 
Highly Cited
1998
Highly Cited
1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes…
Background Improved blood-glucose control decreases the progression of diabetic microvascular disease, but the effect on… 
  • figure 1
  • table 1
  • table 2
  • table 3
  • figure 2
Highly Cited
1998
Highly Cited
1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33)
  • figure 1
  • table 1
  • table 2
  • table 3
  • figure 2
Highly Cited
1998
Highly Cited
1998
Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34)
  • figure 1
  • figure 2
  • table 1
  • figure 3
  • figure 4
Review
1995
Review
1995
U.K. Prospective Diabetes Study 16: Overview of 6 Years' Therapy of Type II Diabetes: A Progressive Disease
The objective of the U.K. Prospective Diabetes Study is to determine whether improved blood glucose control in type II diabetes… 
  • figure 1
  • table 1
  • figure 2
  • table 2
  • figure 3
Highly Cited
1995
Highly Cited
1995
Reconstitution of IKATP: An Inward Rectifier Subunit Plus the Sulfonylurea Receptor
A member of the inwardly rectifying potassium channel family was cloned here. The channel, called BIR (Kir6.2), was expressed in… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy, Terms of Service, and Dataset License
ACCEPT & CONTINUE